Valeant Edges Up 15% After Announcing That It Will Acquire Salix By: TalkMarkets February 23, 2015 at 20:05 PM EST Valeant has agreed to acquire Salix For $10.4 billion or $158 per share in an all cash deal. Read More >> Related Stocks: Actavis Plc Valeant Pharmaceuticals International, Inc.
